Biology, prognosis and response to therapy of breast carcinomas according to HER2 score (original) (raw)
Efficacy of anti-HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancer
Elisa Van Raemdonck
Breast Cancer Research and Treatment, 2020
View PDFchevron_right
Clinical Relevance of HER2 Overexpression/Amplification in Patients With Small Tumor Size and Node-Negative Breast Cancer
Giuseppe Viale
Journal of Clinical Oncology, 2009
View PDFchevron_right
Breast Carcinoma, Receptor Status, and Her2 neu Overexpression Revisited
R. Puvitha, Shifa Ibrahim
View PDFchevron_right
Clinical relevance and concordance of HER2 status in local and central testing-an analysis of 1581 HER2-positive breast carcinomas over 12 years
Christoph Salat
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2018
View PDFchevron_right
Comparison between Estrogen Receptors, Progesterone Receptors and Her2 Receptors with Histopathlogical and Prognostic Parameters in Primary Breast Cancer in Egyptian Patients
Mohamed Fathy Abohashim
View PDFchevron_right
Estrogen, progesterone and HER2 receptor expression in breast tumors of patients, and their usage of HER2-targeted therapy, in a tertiary care centre in India
V. Parmar
Indian Journal of Cancer, 2011
View PDFchevron_right
Prognostic Significance of Low HER2 Expression in Patients With Early Hormone Receptor Positive Breast Cancer
Ippokratis Korantzis
Cancer Diagnosis & Prognosis
View PDFchevron_right
Her 2 Overexpression in Breast Carcinoma; Its Significance and Association with Age and Tumor Grade
Komail Malik
2014
View PDFchevron_right
Progression and treatment of HER2-positive breast cancer
Barbara Hocevar
Cancer Chemotherapy and Pharmacology, 2010
View PDFchevron_right
HER2 Status in Male Breast Carcinoma: a Single North African Institution Experience of 10 Cases and Review of the Literature
Peertechz Journals
View PDFchevron_right
Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma
Mohamed Guermazi
World Journal of Surgical Oncology, 2008
View PDFchevron_right
Spectrum of Breast Carcinoma in Relation to ER, PR and HER2/neu Status with Special Emphasis on Changing Patterns in Recurrence
Madhu Kumari
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2018
View PDFchevron_right
Association of HER2 Overexpression and Prognosis in Small (T1N0) Primary Breast Cancers
Ulrike Nitz
Breast Care, 2013
View PDFchevron_right
Comparison between her2, estrogen receptors and progesterone receptors in primary breast carcinomas and matched lymph node metastases
Ihab atta
Turkish Journal of Pathology, 2016
View PDFchevron_right
Immunohistochemical evaluation of positive hormone receptors and HER2 overexpression in women with breast cancer
AHMED BABAN
Ibnosina Journal of Medicine and Biomedical Sciences, 2016
View PDFchevron_right
Standardized Assessment of the HER2 Status in Breast Cancer by Immunohistochemistry
Linda Schiffhauer
Laboratory Medicine, 2011
View PDFchevron_right
Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study
Wendy Raymond
The Breast, 2003
View PDFchevron_right
Estrogen receptor (ER), progesterone receptor (PR), and HER2 expression pre- and post- neoadjuvant chemotherapy in primary breast carcinoma: A single institutional experience
Aziza Nassar
International journal of clinical and experimental pathology
View PDFchevron_right
Target Therapy in HER2-Overexpressing Breast Cancer Patients
rosalba amodio
OMICS: A Journal of Integrative Biology, 2011
View PDFchevron_right
HER2 overexpression in various tumor types, focussing on its relationship to the development of invasive breast cancer
P. Casalini, Elda Tagliabue
Annals of Oncology, 2001
View PDFchevron_right
HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors
patrizia casalini
Clinical cancer …, 2002
View PDFchevron_right
HER2 status in patients with breast carcinoma is not modified selectively by preoperative chemotherapy and is stable during the metastatic process
Pascal Genin
Cancer, 2002
View PDFchevron_right
Clinico-pathological study of breast carcinoma with correlation to hormone receptor status & HER2/neu
IP Innovative Publication Pvt. Ltd.
2016
View PDFchevron_right
Immunohistochemical Study on Hormone Receptors and HER2 Status in Invasive Breast Carcinoma and its Therapeutic Implications
Iqbal Karim
Bangladesh Critical Care Journal, 2019
View PDFchevron_right